Britain to give COVID-19 shots to key vaccine supply workers

LONDON (Reuters) - Britain on Tuesday said it would give COVID-19 shots to up to 2,000 people working in vaccine supply chains, after AstraZeneca requested protection for its workers trying to deliver an ambitious vaccine rollout programme. AstraZeneca research chief Mene Pangalos last week said that COVID-19 outbreaks were hindering the company's vaccine workforce, and requested that they were prioritised to receive a shot. 'Highly trained workers who have been identified by the government as being irreplaceable and crucial to the delivery of vaccine supplies will be offered vaccines,' the health ministry said in a statement.

Reuters January 20, 2021 00:10:41 IST
Britain to give COVID-19 shots to key vaccine supply workers

COVID-19 shots to key vaccine supply workers" src="https://images.firstpost.com/wp-content/themes/firstpost/images/220x220_Watermark.jpg" alt="Britain to give COVID19 shots to key vaccine supply workers" width="300" height="225" />

LONDON (Reuters) - Britain on Tuesday said it would give COVID-19 shots to up to 2,000 people working in vaccine supply chains, after AstraZeneca requested protection for its workers trying to deliver an ambitious vaccine rollout programme.

AstraZeneca research chief Mene Pangalos last week said that COVID-19 outbreaks were hindering the company's vaccine workforce, and requested that they were prioritised to receive a shot.

"Highly trained workers who have been identified by the government as being irreplaceable and crucial to the delivery of vaccine supplies will be offered vaccines," the health ministry said in a statement.

"This will reduce the risk of an outbreak that would disrupt the immediate supply chain, which could have a significant impact on the largest vaccination programme in British history."

Eligible staff include those working for AstraZeneca and Pfizer involved in making the drug substance, the "fill and finish" of the vials, batch testing and logistics.

Britain is aiming to vaccinate up to 15 million high risk people with first doses of Pfizer or AstraZeneca's shot by mid-February. Latest figures show that nearly 4.3 million people have received initial doses of a COVID-19 vaccine.

(Reporting by Alistair Smout; editing by William James)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Subscribe to Moneycontrol Pro at ₹499 for the first year. Use code PRO499. Limited period offer. *T&C apply

also read

Rio Tinto chairman, director, to step down after rock shelter destruction
Business

Rio Tinto chairman, director, to step down after rock shelter destruction

MELBOURNE (Reuters) - Rio Tinto Ltd said on Wednesday its chair and a board director would step down, bowing to investor pressure over the destruction of two ancient Aboriginal rock shelters for an iron ore mine last year in Western Australia. Simon Thompson will step down as chairman following next year's annual general meetings, while non-executive director Michael L'Estrange will also retire from the board after this year's meetings, Rio said in a statement. "I am ultimately accountable for the failings that led to this tragic event," Thompson said in the statement on Wednesday.

Sunak to promise 'whatever it takes' in new COVID budget plan
Business

Sunak to promise 'whatever it takes' in new COVID budget plan

By William Schomberg LONDON (Reuters) - Finance minister Rishi Sunak will promise on Wednesday to do "whatever it takes", including a five-month extension of Britain's huge jobs rescue plan, to steer the economy through what he hopes will be the final months of COVID restrictions. Sunak has already racked up Britain's highest borrowing since World War Two and will turn to the bond markets again in his budget speech, saying the task of fixing the public finances will only begin once a recovery is in sight

Asian shares nudge higher in defensive trade, dollar soft
Business

Asian shares nudge higher in defensive trade, dollar soft

NEW YORK (Reuters) - Asian shares edged higher on Wednesday as investors shrugged off concerns that stocks may have rallied too far too fast in the past year, and focused instead on optimism that more imminent U.S.